Browse diseases

…Introduction Intestinal disease is the main driver of GI related morbidity in Systemic Sclerosi…

…tal technologies and artificial intelligence (AI) are reshaping inflammatory bowel disease (IBD) care across the UK. Beyond established AI applications in…

…Small bowel metastasis from colorectal cancer (CRC) is rare and difficult to diagnose, especially in patients…

…e Trusts received the highest number of requests.Infliximab for IBD was the most frequently requested drug; haematology was the lea…

…inical results that reposition these drugs for the treatment of colitis and colitis-associated cancer (CAC). Our results are consistent…

… monotherapy, 57 (56.4%) had Crohn’s disease and 44 (43.6%) had ulcerative colitis. Treatment persistence at 12 months was 91.1% (92/101), with su…

…s for inflammasome signalling in various types of GI cancer and IBD. Additionally, beyond local gut functions, microbiota influence…

…fferent patient cohorts of inflammatory bowel disease (IBD) and decompensated cirrhosis, focusing on differences in sociodemographic characteristics.De…

…ancreatitis and inflammatory bowel diseases (IBD), particularly Crohn’s disease, disorders that are associated with visceral hypersensitivity s…

… development of early toxicity mitigation strategies in routine NSCLC practice.Acknowledgements This study was conducted using de-ide…

…nts prior to ICB therapy (Cohorts 1 and 2) and individuals with inflammatory bowel disease (IBD) or healthy controls (Cohort 3) ( table 1). Events with gr…

…Background Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s diseases, is recognized as an autoimmune disor…